2191.T实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (22 Aug 2022 @ 14:15):

Stats
今日成交量	12.99M
平均成交量	0
市值	0.00
Last Dividend	¥0.800 ( 2012-12-26 )
Next Dividend	¥0 ( N/A )
P/E	-0.0564
ATR14	¥0 (0.00%)

tella, Inc. 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

tella, Inc. 财务报表

Annual	2021
营收:	¥106.41M
毛利润:	¥-98.59M (-92.65 %)
EPS:	¥-9.04

FY	2021
营收:	¥106.41M
毛利润:	¥-98.59M (-92.65 %)
EPS:	¥-9.04

FY	2020
营收:	¥76.36M
毛利润:	¥-37.44M (-49.02 %)
EPS:	¥-45.26

FY	2019
营收:	¥202.18M
毛利润:	¥44.81M (22.16 %)
EPS:	¥-53.81

Financial Reports:

No articles found.

tella, Inc. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

tella, Inc. Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	¥0.600	2010-12-28
Last Dividend	¥0.800	2012-12-26
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	¥1.400	--
Avg. Dividend % Per Year	0.00%	--
Score	0.22	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-10-04)

¥0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

0.22

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
7613.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
6810.T	Ex Dividend Knight	2023-09-28	Annually	0.00%
6165.T	Ex Dividend Junior	2023-09-28	Annually	0.00%
4902.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
4064.T	Ex Dividend Junior	2023-09-28	Annually	0.00%
3284.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
2327.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
9274.T	Ex Dividend Junior	2023-09-28	Annually	0.00%
8016.T	Ex Dividend Junior	2024-02-28	Annually	0.00%
7267.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-8.92	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-2.91	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-1.442	1.500	-10.00	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	5.18	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	1.043	0.800	8.57	6.85	[0.8 - 2.5]
cashRatioTTM	1.043	1.500	5.31	7.97	[0.2 - 2]
debtRatioTTM	0.00805	-1.500	9.87	-10.00	[0 - 0.6]
interestCoverageTTM	-6 403.73	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	-7.57	2.00	-2.52	-5.05	[0 - 30]
freeCashFlowPerShareTTM	-7.57	2.00	-3.79	-7.57	[0 - 20]
debtEquityRatioTTM	0.0132	-1.500	9.95	-10.00	[0 - 2.5]
grossProfitMarginTTM	-0.927	1.000	-10.00	-10.00	[0.2 - 0.8]
operatingProfitMarginTTM	-7.46	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-309.84	1.000	-10.00	-10.00	[0.2 - 2]
assetTurnoverTTM	0.326	0.800	-1.160	-0.928	[0.5 - 2]
Total Score				-4.17

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-0.227	1.000	-0.124	0	[1 - 100]
returnOnEquityTTM	-1.442	2.50	-10.00	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-7.57	2.00	-2.52	-7.57	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-7.57	2.00	-2.52	-5.05	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.00159	1.500	-3.32	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-7.65	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-3.52

tella, Inc.

tella, Inc. researches and develops regenerative and cell medicines. The company offers techniques and operational knowhow associated with dendritic cell vaccine therapy to affiliated medical institutions for the treatment of cancer. It is also involved in the provision of consultation services on the establishment and maintenance of cell processing centers, and on introduction of management systems for cell cultivation; and lease of standard operating procedure and regular checks on manufacturing operation management and training of cell cultivation technicians. In addition, the company provides consultation services on training of expertise regarding treatment practice; and support services for the assessment of therapies, documentation required for treatment practice, and cognition and information providing activities for physicians and patients. tella, Inc. was founded in 2004 and is based in Tokyo, Japan.